22(top 2%)
papers
244(top 5%)
citations
6(top 5%)
h-index
9(top 5%)
g-index
29
all documents
270
doc citations
125
citing journals

Top Articles

#TitleJournalYearCitations
1Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroupsAnnals of the Rheumatic Diseases2016127
2Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroupsAnnals of the Rheumatic Diseases201981
3Prediction of response to methotrexate in rheumatoid arthritisExpert Review of Clinical Immunology201823
4The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortRheumatology201710
5HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritisPediatric Rheumatology20159
6Previously reported PDE3A–SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohortPharmacogenomics20169
7Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samplesArthritis Research and Therapy20156
8Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathiesArthritis Research and Therapy20164
9OP0257 Differential DNA Methylation Related to Response to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisAnnals of the Rheumatic Diseases20141
10THU0486 Correlating Whole Genome Expression Profiling with Treatment Response in Rheumatoid Arthritis PatientsAnnals of the Rheumatic Diseases20140
11THU0020 Predicting Response to the Anti-Tnf Biologic, Etanercept in Rheumatoid Arthritis Patients Using Microrna Expression ProfilingAnnals of the Rheumatic Diseases20150
12AB0006 A Genome-Wide Association Study for Methotrexate-Induced Pneumonitis in Rheumatoid ArthritisAnnals of the Rheumatic Diseases20150
13OP0122 Fine Mapping of the CHR 22Q13.1 Juvenile Idiopathic Arthritis Risk LocusAnnals of the Rheumatic Diseases20150
14THU0068 Absolute Monocyte Counts Are Associated with Adverse EULAR Response after 6 Months of Treatment with A Biologic Agent for Rheumatoid ArthritisAnnals of the Rheumatic Diseases20160
15219 Validation of a Distinct Psoriatic Arthritis Risk Variant at IL23RRheumatology20160
16OP0235 Identification of Novel Cd4+ Lymphocyte Expression Quantitative Trait Loci in Untreated Early Arthritis PatientsAnnals of the Rheumatic Diseases20160
17SAT0011 Replication of A Distinct Psoriatic Arthritis Risk Variant at IL23RAnnals of the Rheumatic Diseases20160
18SAT0018 Preliminary Analysis Reveals An Interferon Signature Is Associated with Non-Response To Etanercept in Rheumatoid Arthritis PatientsAnnals of the Rheumatic Diseases20160
19A6.13 Identification of novel expression quantitative trait loci in CD4+T cells of untreated early arthritis patientsAnnals of the Rheumatic Diseases20160
20OP0236 Whole Transcriptome Investigation of Response To Anti-TNF Treatment in Rheumatoid ArthritisAnnals of the Rheumatic Diseases20160
21THU0002 Etanercept and adalimumab exhibit heterogeneous early signatures of response in rheumatoid arthritis therapy20170
2205.10 Comparison of cd4+ and b lymphocyte expression quantitative trait associations at ra risk loci in untreated early arthritis patients20170
23FRI0724 Predictors of presenteeism and absenteeism in patients commencing treatment with methotrexate monotherapy or biologic therapy for rheumatoid arthritis20170
24THU0008 Linking genetics to t-cell phenotype in jia: rational for il-2 therapy20180
25P124 Altered CD4+ T cell DNA methylation in early rheumatoid arthritis20180
26SAT0062 STRATIFIED MEDICINE FOR RHEUMATOID ARTHRITIS: PREDICTING RESPONSE TO BIOLOGIC THERAPY USING IMMUNE CELL SIGNATURES20190
27OP0189 GENETICS OF JUVENILE IDIOPATHIC ARTHRITIS: THE IDENTIFICATION OF A NOVEL RISK LOCUS AND CLINICAL SUBGROUP ANALYSIS20190
28POS0033 GENETIC INVESTIGATION OF TUMOUR NECROSIS FACTOR INHIBITOR IMMUNOGENICITY IN PATIENTS WITH RHEUMATOID ARTHRITISAnnals of the Rheumatic Diseases20220
29P042 Using a Genetic PROBability tool (G-PROB) to aid diagnosis of patients with inflammatory arthritis: results from the Norfolk Arthritis RegisterRheumatology20230